# Amgen (AMGN) — Analyst Forecast

AMGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/amgn/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | Wells Fargo | Maintained | Equal-Weight | $430.00 |
| Oct 12, 2026 | BMO Capital | Maintained | Market Perform | $415.00 |
| Oct 9, 2026 | UBS | Maintained | Buy | $470.00 |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | $440.00 |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | $430.00 |
| Oct 7, 2026 | Morgan Stanley | Maintained | Equal-Weight | $359.00 |
| Oct 7, 2026 | Truist Securities | Maintained | Hold | $380.00 |
| Sep 29, 2026 | Scotiabank | Maintained | Sector Outperform | $500.00 |
| Sep 10, 2026 | HSBC | Downgraded | Buy → Hold | $425.00 |
| Sep 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | $400.00 |
| Sep 8, 2026 | BMO Capital | Downgraded | Outperform → Market Perform | $450.00 |
| Sep 4, 2026 | Wells Fargo | Maintained | Equal-Weight | $435.00 |
| Aug 20, 2026 | Piper Sandler | Maintained | Overweight | $457.00 |
| Aug 19, 2026 | Argus Research | Maintained | Buy | $460.00 |
| Aug 18, 2026 | Cantor Fitzgerald | Maintained | Neutral | $400.00 |
| Aug 18, 2026 | Mizuho | Maintained | Neutral | $352.00 |
| Aug 14, 2026 | Barclays | Maintained | Equal-Weight | $380.00 |
| Aug 10, 2026 | Guggenheim | Maintained | Neutral | $388.00 |
| Aug 7, 2026 | Citigroup | Maintained | Neutral | $405.00 |
| Aug 6, 2026 | Bernstein | Maintained | Market Perform | $345.00 |

## Frequently Asked Questions

### What is the latest analyst rating on AMGN?

On Oct 12, 2026, Wells Fargo maintained Amgen at Equal-Weight with a price target of $430.00.

## Similar Stocks

- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [GILD](https://www.lighthorse.io/tickers/gild) — Gilead Sciences, Inc. - Common Stock
- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares
- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock
- [BMY](https://www.lighthorse.io/tickers/bmy) — Bristol-Myers Squibb Company Common Stock
- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [REGN](https://www.lighthorse.io/tickers/regn) — Regeneron Pharmaceuticals, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).